HOUSTON, July 25, 2017 /PRNewswire/ -- Black Beret
Life Sciences LLC has finalized the acquisition of Okyanos
Operating Company, Ltd., a state-of-the-art adult stem cell and
regenerative medicine center based in Freeport, Grand Bahama.
Dr. W.E. ("Ed") Bosarge founded Black Beret Life Sciences (BBLS)
to identify and manage investments in game-changing biotechnology
innovations on behalf of the Bosarge family office and other
investors. Since its launch in 2014, BBLS has invested in and
supported key research and development efforts in regenerative
medicine, obesity and diabetes, and cancer therapeutics.
Marc S. Penn, MD, PhD, FACC,
serves as CEO and Chief Medical and Science Officer at BBLS,
leading teams of researchers specializing in diverse medical
disciplines. "BBLS invests in and helps manage companies which
could dramatically improve patient outcomes for chronic conditions.
The Okyanos Center for Regenerative Medicine provides adult stem
cell therapy in a regulated jurisdiction with the highest level of
safety and care," said Dr. Penn. "We look forward to the continued
growth of Okyanos in collaboration with the National Stem Cell
Ethics Committee of the Bahamas.
Our goal is to develop an international stem cell treatment network
that is deeply rooted in patient safety, the best medical practices
and transparency. We will rigorously follow-up on our patient's
treatment utilizing clinically meaningful measures to build a
database of knowledge to accelerate the development of the
regenerative medicine field globally."
Founded in 2011, Okyanos is located in Freeport, Grand Bahama, just 30 minutes from
southern Florida. Okyanos is
licensed by the Bahamas' National
Stem Cell Ethics Committee (NSCEC), providing safe, regenerative
therapies to patients with chronic conditions so they can live
longer and healthier lives.
ABOUT BLACK BERET LIFE SCIENCES
Black Beret Life
Sciences (BBLS) is the investment and management arm of the
Houston-based Bosarge Family
Office. The firm was established in 2014 by Dr. Ed Bosarge to organize and manage investments in
potentially game-changing bio-technology and healthcare companies
focused on regenerative medicine, anti-aging and immunotherapy.
With an overall goal of extending healthier life, BBLS'
portfolio of managed investments includes companies and research
across an array of disease spectrums, including diabetes,
neurodegeneration, osteoarthritis, cancer immunotherapy and various
conditions related to aging. BBLS is based in Houston, TX, with offices worldwide. Learn
more at https://www.bbls.net.
ABOUT OKYANOS CENTER FOR REGENERATIVE MEDICINE (OH –
KEY – AH – NOS)
A state-of-the art regenerative medicine
center delivering cutting edge therapies for chronic conditions,
Okyanos is a leading adult stem cell therapy provider with world
class physicians and staff. Okyanos helps people with
chronic, degenerative diseases including orthopedic, cardiac,
neurologic and urologic conditions return to a more normal life
through a treatment approach using fat-derived stem cells. Based in
Freeport, Grand Bahama, Okyanos is
licensed under the Bahamas Stem Cell Therapy and Research Act. The
literary name Okyanos, the Greek god of the river Okeanos,
symbolizes restoration of blood flow. Learn more at
www.okyanos.com.
Media Contact:
Erik Borg
Ph: 212-584-7829
erik@Theleadpr.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/black-beret-life-sciences-llc-leads-acquisition-of-okyanos-center-for-regenerative--medicine-300493666.html
SOURCE Black Beret Life Sciences LLC